SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-149921
Filing Date
2023-05-22
Accepted
2023-05-22 08:00:31
Documents
18
Period of Report
2023-05-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d457287d8k.htm   iXBRL 8-K 59460
2 EX-10.1 d457287dex101.htm EX-10.1 25597
3 EX-10.2 d457287dex102.htm EX-10.2 57715
4 EX-10.3 d457287dex103.htm EX-10.3 162489
5 EX-99.1 d457287dex991.htm EX-99.1 10909
9 GRAPHIC g457287g0518234809183.jpg GRAPHIC 2565
10 GRAPHIC g457287g95x76.jpg GRAPHIC 11199
  Complete submission text file 0001193125-23-149921.txt   545831

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA atha-20230518.xsd EX-101.SCH 2835
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE atha-20230518_lab.xml EX-101.LAB 18737
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atha-20230518_pre.xml EX-101.PRE 11697
12 EXTRACTED XBRL INSTANCE DOCUMENT d457287d8k_htm.xml XML 3471
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39503 | Film No.: 23942465
SIC: 2836 Biological Products, (No Diagnostic Substances)